Skip to main content
https://pbs.twimg.com/media/FT0uIA-XsAEvxdi.png
Phase 3 RCT upadacitinib in nrAxSpA. Clinical (ASAS40), PRO, and radiologic response seen at week 14 vs placebo @RheumNow #EULAR2022 OP0016 https://t.co/s3Vf4QiiAD https://t.co/gzlxZ3sxHF
Richard Conway
01-06-2022
×